Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02525497
Other study ID # MD-PD-2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2015
Est. completion date December 2017

Study information

Verified date December 2019
Source Chinese PLA General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a randomized, multi-center,crossover study of a domestic FM peritoneal dialysis machine and Baxter HOMECHOICE.It aims to verify safety, effectiveness and manipulability of a domestic peritoneal dialysis machine.


Description:

Our study is a randomized, multi-center,crossover study. It compares a domestic FM peritoneal dialysis machine with Baxter HOMECHOICE.It aims to verify safety, effectiveness and manipulability of a domestic peritoneal dialysis machine.


Recruitment information / eligibility

Status Completed
Enrollment 360
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Age =18, male or female Dialysis duration:=30 days Sign the written informed consent

Exclusion Criteria:

Hemodialysis Exit site infection or tunnel infection Peritonitis =30 days before screening Catheter mechanical failure Anti-HIV positive Allergic to components of dialysate Comorbidity:Active, residual malignant tumor, or systemic infection, liver cirrhosis, severe congestive heart failure,hypertension Poor compliance Pregnant or lactating, women of childbearing age do not agree to use effective contraceptive measures during the trial Has a history of alcoholism and drug abuse (defined as illegal drugs) Any circumstances when patients are believed unsuitable for this trial

Study Design


Intervention

Device:
FM peritoneal dialysis machine
FM peritoneal dialysis machine APD 10L/10h
HOMECHOICE peritoneal dialysis machine
HOMECHOICE peritoneal dialysis machine APD 10L/10h

Locations

Country Name City State
China Chinese PLA General Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Chinese PLA General Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other The accuracy of filling temperature 1 day
Other Serum sodium before and after dialysis 1 day
Other Serum potassium before and after dialysis 1 day
Other Serum calcium before and after dialysis 1 day
Other Serum phosphorus before and after dialysis 1 day
Other Serum carbon dioxide binding force before and after dialysis 1 day
Other Serum creatinine before and after dialysis 1 day
Other Serum urea nitrogen before and after dialysis 1 day
Primary Daily peritoneal Kt/V 1 day
Secondary The accuracy of filling 1 day
See also
  Status Clinical Trial Phase
Completed NCT00172211 - Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients N/A
Completed NCT02964429 - Determination In-vivo KUF for Diacap Pro Hemodialyser N/A
Completed NCT01779557 - Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate Phase 4